# Surgical Science Sweden AB (SUSRF)

> Healthcare · SE · Reports in SEK

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SUSRF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | kr. 487.82M | kr. 39.30M | kr. 54.63M | kr. 2.83M | kr. 4.51B |
| 2025 | kr. 991.67M | kr. 66.73M | kr. 39.16M | kr. 1.62M | kr. 4.26B |
| 2024 | kr. 892.29M | kr. 132.87M | kr. 90.53M | kr. 235.41M | kr. 4.83B |
| 2023 | kr. 898.31M | kr. 238.07M | kr. 197.56M | kr. 53.26M | kr. 4.35B |
| 2022 | kr. 852.43M | kr. 199.66M | kr. 100.84M | kr. 14.68M | kr. 4.24B |
| 2021 | kr. 437.65M | kr. 102.91M | kr. 29.48M | kr. 12.07M | kr. 3.59B |
| 2020 | kr. 129.89M | kr. 19.34M | kr. -2.47M | kr. 2.32M | kr. 427.05M |
| 2019 | kr. 126.44M | kr. 15.69M | kr. 46.95M | kr. 2.25M | kr. 401.68M |
| 2018 | kr. 83.01M | kr. -5.73M | kr. -3.06M | kr. 4.37M | kr. 79.38M |
| 2017 | kr. 74.97M | kr. -2.92M | kr. -5.40M | kr. 2.76M | kr. 85.52M |
| 2016 | kr. 68.15M | kr. 4.34M | kr. 2.37M | kr. 28.00M | kr. 22.40M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 4.24 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.03 |
| Gross Debt / FCF | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/SUSRF.md)
- [Charts](https://sponda.capital/en/SUSRF/charts.md)
- [Compare](https://sponda.capital/en/SUSRF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.